$RIVN
Rivian Automotive Inc

2022 Q2 Form 10-Q Financial Statement

#000187417822000048 Filed on August 11, 2022

View on sec.gov

Income Statement

Concept 2022 Q2 2022 Q1 2021 Q4
Revenue $364.0M $95.00M $54.00M
YoY Change
Cost Of Revenue $1.068B $597.0M $437.0M
YoY Change
Gross Profit -$704.0M -$502.0M -$383.0M
YoY Change
Gross Profit Margin -193.41% -528.42% -709.26%
Selling, General & Admin $461.0M $530.0M $682.0M
YoY Change 147.85% 338.02% 595.92%
% of Gross Profit
Research & Development $543.0M $547.0M $726.0M
YoY Change 37.82% 89.27% 184.71%
% of Gross Profit
Depreciation & Amortization $161.0M $118.0M $113.0M
YoY Change 666.67% 742.86% 841.67%
% of Gross Profit
Operating Expenses $1.004B $1.077B $2.071B
YoY Change 73.1% 162.68% 486.69%
Operating Profit -$1.708B -$1.579B -$2.454B
YoY Change 194.48% 285.12%
Interest Expense $24.00M $22.00M -$21.00M
YoY Change 2300.0% 340.0% 2000.0%
% of Operating Profit
Other Income/Expense, Net $1.000M $5.000M -$3.000M
YoY Change 0.0% -400.0%
Pretax Income -$1.709B -$1.593B -$2.461B
YoY Change 194.66% 284.78% 597.17%
Income Tax $3.000M $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.712B -$1.593B -$2.461B
YoY Change 195.17% 284.78% 597.17%
Net Earnings / Revenue -470.33% -1676.84% -4557.41%
Basic Earnings Per Share -$1.89 -$1.77
Diluted Earnings Per Share -$1.89 -$1.77 -$12.06M
COMMON SHARES
Basic Shares Outstanding 908.0M shares 901.0M shares
Diluted Shares Outstanding 908.0M shares 901.0M shares

Balance Sheet

Concept 2022 Q2 2022 Q1 2021 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $14.92B $16.43B $18.13B
YoY Change 307.96%
Cash & Equivalents $14.92B $16.43B $18.13B
Short-Term Investments
Other Short-Term Assets $92.00M $98.00M $126.0M
YoY Change -54.23% 306.45%
Inventory $655.0M $494.0M $274.0M
Prepaid Expenses
Receivables $62.00M $22.00M $26.00M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $15.73B $17.05B $18.56B
YoY Change 307.67% 515.35%
LONG-TERM ASSETS
Property, Plant & Equipment $3.526B $3.396B $3.183B
YoY Change 38.76% 120.28%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $627.0M $585.0M $324.0M
YoY Change 589.01% 431.15%
Total Long-Term Assets $4.439B $4.251B $3.735B
YoY Change 68.66% 135.5%
TOTAL ASSETS
Total Short-Term Assets $15.73B $17.05B $18.56B
Total Long-Term Assets $4.439B $4.251B $3.735B
Total Assets $20.17B $21.30B $22.29B
YoY Change 210.75% 384.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $732.0M $571.0M $483.0M
YoY Change 260.59% 436.67%
Accrued Expenses $777.0M $746.0M $667.0M
YoY Change 35.84% 50.56%
Deferred Revenue $92.00M $81.00M $74.00M
YoY Change 164.29%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Total Short-Term Liabilities $1.753B $1.524B $1.313B
YoY Change 114.04% 114.89%
LONG-TERM LIABILITIES
Long-Term Debt $1.228B $1.227B $1.226B
YoY Change 61300.0% 2508.51%
Other Long-Term Liabilities $47.00M $30.00M $23.00M
YoY Change -68.87% 2200.0%
Total Long-Term Liabilities $1.275B $1.257B $1.249B
YoY Change 733.33% 2502.08%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.753B $1.524B $1.313B
Total Long-Term Liabilities $1.275B $1.257B $1.249B
Total Liabilities $3.303B $3.037B $2.780B
YoY Change 239.81% 274.66%
SHAREHOLDERS EQUITY
Retained Earnings -$9.679B -$7.967B -$6.374B
YoY Change 278.05%
Common Stock $1.000M $1.000M $1.000M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $16.87B $18.26B $19.51B
YoY Change
Total Liabilities & Shareholders Equity $20.17B $21.30B $22.29B
YoY Change 210.75% 384.44%

Cashflow Statement

Concept 2022 Q2 2022 Q1 2021 Q4
OPERATING ACTIVITIES
Net Income -$1.712B -$1.593B -$2.461B
YoY Change 195.17% 284.78% 597.17%
Depreciation, Depletion And Amortization $161.0M $118.0M $113.0M
YoY Change 666.67% 742.86% 841.67%
Cash From Operating Activities -$1.204B -$1.034B -$1.086B
YoY Change 41.48% 185.64% 305.22%
INVESTING ACTIVITIES
Capital Expenditures -$359.0M $418.0M -$455.0M
YoY Change -58.74% -5.0% 48.69%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$359.0M -$418.0M -$456.0M
YoY Change -58.78% -5.0% 47.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $1.000M
YoY Change -99.96%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 56.00M $0.00 14.76B
YoY Change -97.82% -100.0%
NET CHANGE
Cash From Operating Activities -1.204B -$1.034B -1.086B
Cash From Investing Activities -359.0M -$418.0M -456.0M
Cash From Financing Activities 56.00M $0.00 14.76B
Net Change In Cash -1.507B -$1.452B 13.22B
YoY Change -278.13% -182.03% -2386.85%
FREE CASH FLOW
Cash From Operating Activities -$1.204B -$1.034B -$1.086B
Capital Expenditures -$359.0M $418.0M -$455.0M
Free Cash Flow -$845.0M -$1.452B -$631.0M
YoY Change -4547.37% 81.05% -1760.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Registrant Name
EntityRegistrantName
Rivian Automotive, Inc. / DE
dei Document Type
DocumentType
10-Q
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Amendment Flag
AmendmentFlag
false
dei Entity Central Index Key
EntityCentralIndexKey
0001874178
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-41042
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Address Address Line1
EntityAddressAddressLine1
14600 Myford Road
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92606
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-3544981
dei City Area Code
CityAreaCode
(888)
dei Local Phone Number
LocalPhoneNumber
748-4261
dei Security12b Title
Security12bTitle
Class A common stock, $0.001 par value per share
dei Trading Symbol
TradingSymbol
RIVN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18133000000 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14923000000 usd
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
26000000 usd
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
62000000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
274000000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
655000000 usd
CY2021Q4 us-gaap Other Assets Current
OtherAssetsCurrent
126000000 usd
CY2022Q2 us-gaap Other Assets Current
OtherAssetsCurrent
92000000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
18559000000 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
15732000000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3183000000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3526000000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
228000000 usd
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
286000000 usd
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
324000000 usd
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
627000000 usd
CY2021Q4 us-gaap Assets
Assets
22294000000 usd
CY2022Q2 us-gaap Assets
Assets
20171000000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
483000000 usd
CY2022Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
732000000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
667000000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
777000000 usd
CY2021Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
74000000 usd
CY2022Q2 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
92000000 usd
CY2021Q4 rivn Operating Lease Liability And Other Liabilities Current
OperatingLeaseLiabilityAndOtherLiabilitiesCurrent
89000000 usd
CY2022Q2 rivn Operating Lease Liability And Other Liabilities Current
OperatingLeaseLiabilityAndOtherLiabilitiesCurrent
152000000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1313000000 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1753000000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1226000000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1228000000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
218000000 usd
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
275000000 usd
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23000000 usd
CY2022Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
47000000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
2780000000 usd
CY2022Q2 us-gaap Liabilities
Liabilities
3303000000 usd
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3508000000 shares
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
3508000000 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
900000000 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
900000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
916000000 shares
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
916000000 shares
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
1000000 usd
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
1000000 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
25887000000 usd
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
26547000000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-6374000000 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-9679000000 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
0 usd
CY2022Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1000000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19514000000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
16868000000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
22294000000 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
20171000000 usd
CY2021Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
CY2022Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
364000000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
0 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
459000000 usd
CY2021Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
CY2022Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1068000000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
0 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1665000000 usd
CY2021Q2 us-gaap Gross Profit
GrossProfit
0 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
-704000000 usd
us-gaap Gross Profit
GrossProfit
0 usd
us-gaap Gross Profit
GrossProfit
-1206000000 usd
CY2021Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
394000000 usd
CY2022Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
543000000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
683000000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1090000000 usd
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
186000000 usd
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
461000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
307000000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
991000000 usd
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
580000000 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
1004000000 usd
us-gaap Operating Expenses
OperatingExpenses
990000000 usd
us-gaap Operating Expenses
OperatingExpenses
2081000000 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-580000000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1708000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-990000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3287000000 usd
CY2021Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
0 usd
CY2022Q2 us-gaap Investment Income Interest
InvestmentIncomeInterest
22000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
1000000 usd
us-gaap Investment Income Interest
InvestmentIncomeInterest
25000000 usd
CY2021Q2 us-gaap Interest Expense
InterestExpense
1000000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
24000000 usd
us-gaap Interest Expense
InterestExpense
6000000 usd
us-gaap Interest Expense
InterestExpense
46000000 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1000000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
6000000 usd
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-580000000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1709000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-994000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3302000000 usd
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3000000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-580000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1712000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-994000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3305000000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-580000000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-580000000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1712000000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1712000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-994000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-994000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3305000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3305000000 usd
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.74
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.74
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.89
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.66
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101000000 shares
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
908000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
908000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
904000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
904000000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-580000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1712000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-994000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3305000000 usd
CY2021Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
0 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000000 usd
CY2021Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-580000000 usd
CY2022Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1713000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-994000000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3306000000 usd
CY2020Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
504000000 shares
CY2020Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
5244000000 usd
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101000000 shares
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1384000000 usd
CY2021Q1 rivn Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
72000000 shares
CY2021Q1 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
2650000000 usd
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-414000000 usd
CY2021Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
576000000 shares
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
7894000000 usd
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101000000 shares
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1797000000 usd
CY2021Q2 rivn Temporary Equity Stock Issued During Period Shares New Issues
TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
0 shares
CY2021Q2 us-gaap Temporary Equity Stock Issued During Period Value New Issues
TemporaryEquityStockIssuedDuringPeriodValueNewIssues
0 usd
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2000000 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-580000000 usd
CY2021Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
576000000 shares
CY2021Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
7894000000 usd
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
101000000 shares
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2375000000 usd
CY2021Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2021Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
900000000 shares
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
19514000000 usd
CY2022Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1000000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-1593000000 usd
CY2022Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
338000000 usd
CY2022Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
901000000 shares
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
18260000000 usd
CY2022Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
57000000 usd
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
264000000 usd
CY2022Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1712000000 usd
CY2022Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
CY2022Q2 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
0 usd
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
916000000 shares
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
16868000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-994000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3305000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
279000000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
559000000 usd
us-gaap Inventory Write Down
InventoryWriteDown
0 usd
us-gaap Inventory Write Down
InventoryWriteDown
301000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-8000000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-63000000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
10000000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
620000000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
5000000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-18000000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5000000 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
19000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
111000000 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
421000000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
10000000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
18000000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
0 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
52000000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-1000000 usd
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
32000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-851000000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2238000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
871000000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
777000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-871000000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-777000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2653000000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
58000000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
85000000 usd
CY2022Q2 us-gaap Restricted Cash
RestrictedCash
540000000 usd
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
2000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2568000000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
56000000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
846000000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-2960000000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3011000000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
18423000000 usd
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3857000000 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15463000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
425000000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
358000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
86000000 usd
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
84000000 usd
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2022Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 usd
CY2021Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
13500000000 usd
us-gaap Use Of Estimates
UseOfEstimates
Accounting estimates are an integral part of the condensed consolidated financial statements. These estimates require the use of judgments and assumptions that may affect the reported amounts of assets, liabilities, revenues, and expenses in the periods presented. The Company believes that the accounting estimates and related assumptions employed by the Company are appropriate and the resulting balances are reasonable under the circumstances. However, due to the inherent uncertainties involved in making estimates, actual results could differ from original estimates, requiring adjustments to these amounts in future periods.
CY2021Q4 us-gaap Restricted Cash
RestrictedCash
290000000 usd
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4049000000 usd
CY2021Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
236000000 usd
CY2022Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
488000000 usd
CY2021Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
9000000 usd
CY2022Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
60000000 usd
CY2021Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
29000000 usd
CY2022Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
107000000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
274000000 usd
CY2022Q2 us-gaap Inventory Net
InventoryNet
655000000 usd
us-gaap Inventory Write Down
InventoryWriteDown
301000000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Counterparty Credit Risk </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to concentration of counterparty credit risk consist of cash and cash equivalents, restricted cash, deposits, derivatives, and loans. The Company is exposed to credit risk to the extent that its cash balance with a financial institution is in excess of Federal Deposit Insurance Company insurance limits. The degree of counterparty credit risk will vary based on many factors, including the duration of the transaction and the contractual terms of the agreement. Management evaluates and approves credit standards and oversees the credit risk management function related to investments. As of December 31, 2021 and June 30, 2022, all of the Company’s cash and cash equivalents were placed at financial institutions that management believes are of high credit quality. These balances are typically in excess of insured limits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Supply Risk</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is subject to risks related to its dependence on suppliers, the majority of which are single source providers of parts or components for the Company’s products. Any inability of the Company’s suppliers to deliver necessary product components, including semiconductors, at timing, prices, quality, and volumes that are acceptable to the Company could have a material and adverse impact on Rivian’s business, growth prospects, and financial and operating results. </span></div>The Company’s manufacturing facility in Normal, Illinois (the “Normal Factory”) is operational, and Rivian is continuing to invest in the Normal Factory. The Company’s ability to sustain production depends, among other things, on the readiness and solvency of suppliers and vendors through various macroeconomic factors, including factors resulting from the COVID-19 pandemic, and economic uncertainties, such as geopolitical instability and its effects on inflation and commodity prices.
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3416000000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
233000000 usd
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
523000000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3183000000 usd
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
3526000000 usd
CY2021Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
21000000 usd
CY2022Q2 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
161000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35000000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
279000000 usd
CY2021Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1250000000 usd
CY2022Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1250000000 usd
CY2021Q4 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
24000000 usd
CY2022Q2 us-gaap Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net
DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
22000000 usd
CY2021Q4 us-gaap Long Term Debt
LongTermDebt
1226000000 usd
CY2022Q2 us-gaap Long Term Debt
LongTermDebt
1228000000 usd
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
0 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1226000000 usd
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
1228000000 usd
CY2021Q4 rivn Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
311000000 usd
CY2022Q2 rivn Accrued Capital Expenditures Current
AccruedCapitalExpendituresCurrent
270000000 usd
CY2021Q4 rivn Accrued Other Products And Services Current
AccruedOtherProductsAndServicesCurrent
182000000 usd
CY2022Q2 rivn Accrued Other Products And Services Current
AccruedOtherProductsAndServicesCurrent
152000000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
95000000 usd
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
184000000 usd
CY2021Q4 rivn Accrued Inventory Current
AccruedInventoryCurrent
28000000 usd
CY2022Q2 rivn Accrued Inventory Current
AccruedInventoryCurrent
129000000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
51000000 usd
CY2022Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
42000000 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
667000000 usd
CY2022Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
777000000 usd
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2021Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
CY2022Q2 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
us-gaap Net Income Loss
NetIncomeLoss
-994000000 usd
CY2021Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
0 usd
CY2022Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
242000000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
559000000 usd
CY2021Q4 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
17000000 usd
CY2022Q2 us-gaap Loss Contingency Accrual Carrying Value Current
LossContingencyAccrualCarryingValueCurrent
10000000 usd
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
677000000 shares
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
677000000 shares
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
116000000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
116000000 shares
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-580000000 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-1712000000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3305000000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-580000000 usd
CY2021Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-580000000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-1712000000 usd
CY2022Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1712000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-994000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-994000000 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-3305000000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3305000000 usd
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
908000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
101000000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
904000000 shares
CY2021Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2022Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101000000 shares
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
908000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
101000000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
904000000 shares
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.74
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.74
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.89
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-9.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-9.84
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.66
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.66

Files In Submission

Name View Source Status
0001874178-22-000048-index-headers.html Edgar Link pending
0001874178-22-000048-index.html Edgar Link pending
0001874178-22-000048.txt Edgar Link pending
0001874178-22-000048-xbrl.zip Edgar Link pending
ex-3112022q2.htm Edgar Link pending
ex-3122022q2.htm Edgar Link pending
ex-3212022q2.htm Edgar Link pending
ex-3222022q2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rivn-20220630.htm Edgar Link pending
rivn-20220630.xsd Edgar Link pending
rivn-20220630_g1.jpg Edgar Link pending
Show.js Edgar Link pending
rivn-20220630_cal.xml Edgar Link unprocessable
rivn-20220630_pre.xml Edgar Link unprocessable
rivn-20220630_def.xml Edgar Link unprocessable
rivn-20220630_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable
rivn-20220630_lab.xml Edgar Link unprocessable